Page last updated: 2024-10-26

famotidine and Esophageal and Gastric Varices

famotidine has been researched along with Esophageal and Gastric Varices in 2 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Esophageal and Gastric Varices: Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akahoshi, T1
Kawanaka, H1
Tomikawa, M1
Saeki, H1
Uchiyama, H1
Ikeda, T1
Shirabe, K1
Hashizume, M1
Maehara, Y1
Tanaka, J1
Fujimoto, K1
Iwakiri, R1
Koyama, T1
Sakata, H1
Ohyama, T1
Mizuguchi, M1
Tokunaga, O1

Trials

1 trial available for famotidine and Esophageal and Gastric Varices

ArticleYear
Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).
    Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:12

    Topics: Aged; Esophageal and Gastric Varices; Esophageal pH Monitoring; Esophagitis, Peptic; Famotidine; Fem

2013

Other Studies

1 other study available for famotidine and Esophageal and Gastric Varices

ArticleYear
Hyperplastic polyps following treatment of acute gastric ulcers.
    Internal medicine (Tokyo, Japan), 1994, Volume: 33, Issue:6

    Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Po

1994